Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.87 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.87 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.87 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.87 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 1/20 | 0.48 |
| ▸ | G6PD | P11413 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8971703 | 1.00 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9MCHR1 | |
| SCHEMBL5463183 | 1.00 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9MCHR1 | |
| SCHEMBL8971430 | 1.00 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9MCHR1 | |
| SCHEMBL8971457 | 1.00 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9MCHR1 | |
| SCHEMBL8971261 | 1.00 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9MCHR1 | |
| SCHEMBL8971420 | 1.00 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9MCHR1 | |
| SCHEMBL2537399 | 1.00 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9MCHR1 | |
| SCHEMBL8971225 | 1.00 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9MCHR1 | |
| SCHEMBL8971919 | 1.00 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9MCHR1 | |
| SCHEMBL8970703 | 1.00 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9MCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105524497-A | Super-hydrophobic self-repairing intelligent nano coating and preparation method thereof | UNIV NANJING SCIENCE & TECH | 2016-04-27 | — | — | CN | claimed |
| CN-110114389-B | Emulsion of nitrogen atom-containing polymer or salt thereof, method for producing same, and method for producing particles | 富士胶片株式会社 | 2022-04-01 | — | — | CN | disclosed |
| EP-3698799-B1 | HYPERPHOSPHATEMIA TREATMENT AGENT | FUJIFILM CORP (JP) | 2022-01-26 | — | — | EP | disclosed |
| US-11186685-B2 | Emulsion of nitrogen atom-containing polymer or salt thereof, production method therefor, and production method for particles | FUJIFILM CORPORATION (JP) | 2021-11-30 | — | — | US | disclosed |
| US-11147833-B2 | Therapeutic agent for hyperphosphatemia | FUJIFILM CORPORATION (JP) | 2021-10-19 | — | — | US | disclosed |
| EP-3564292-B1 | EMULSION OF NITROGEN ATOM-CONTAINING POLYMER OR SALT THEREOF, PRODUCTION METHOD THEREFOR, AND PRODUCTION METHOD FOR PARTICLES | FUJIFILM CORP (JP) | 2021-06-16 | — | — | EP | disclosed |
| US-20210121499-A1 | THERAPEUTIC AGENT FOR HYPERPHOSPHATEMIA AND PARTICLES | FUJIFILM CORPORATION (JP) | 2021-04-29 | — | — | US | disclosed |
| EP-3698799-A1 | HYPERPHOSPHATEMIA TREATMENT AGENT | FUJIFILM Corporation (JP) | 2020-08-26 | — | — | EP | disclosed |
| EP-3698798-A1 | HYPERPHOSPHATEMIA TREATMENT AGENT, AND PARTICLES | FUJIFILM Corporation (JP) | 2020-08-26 | — | — | EP | disclosed |
| EP-3564292-A1 | EMULSION OF NITROGEN ATOM-CONTAINING POLYMER OR SALT THEREOF, PRODUCTION METHOD THEREFOR, AND PRODUCTION METHOD FOR PARTICLES | Fujifilm Corporation (JP) | 2019-11-06 | — | — | EP | disclosed |
| US-20190315932-A1 | EMULSION OF NITROGEN ATOM-CONTAINING POLYMER OR SALT THEREOF, PRODUCTION METHOD THEREFOR, AND PRODUCTION METHOD FOR PARTICLES | FUJIFILM CORPORATION (JP) | 2019-10-17 | — | — | US | disclosed |
| CN-105524497-A | Super-hydrophobic self-repairing intelligent nano coating and preparation method thereof | UNIV NANJING SCIENCE & TECH | 2016-04-27 | — | — | CN | disclosed |
| CN-105441956-A | PH/Mg<2+>-stimulus-response nano container and preparation method thereof | UNIV NANJING SCIENCE & TECH | 2016-03-30 | — | — | CN | disclosed |
| EP-0493601-B1 | LIQUID-CRYSTAL COPOLYMER, PRODUCTION THEREOF, DIENE COMPOUND USED IN SAID PRODUCTION, AND PRODUCTION OF SAID COMPOUND | IDEMITSU KOSAN CO (JP) | 1996-03-20 | — | — | EP | disclosed |
| EP-0431387-B1 | Basic polysaccharides | WOLFF WALSRODE AG (DE) | 1995-09-06 | — | — | EP | disclosed |
| US-5425897-A | Electrooptics | IDEMITSU KOSAN CO., LTD. (JP) | 1995-06-20 | — | — | US | disclosed |
| US-5380915-A | Copolymers of polydimethylsiloxane with diene ethers | IDEMITSU KOSAN CO., LTD. (JP) | 1995-01-10 | — | — | US | disclosed |
| US-5281685-A | Polyether pendant groups, polysiloxane repeating units | IDEMITSU KOSAN CO., LTD. (JP) | 1994-01-25 | — | — | US | disclosed |
| EP-0493601-A1 | LIQUID-CRYSTAL COPOLYMER, PRODUCTION THEREOF, DIENE COMPOUND USED IN SAID PRODUCTION, AND PRODUCTION OF SAID COMPOUND | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1992-07-08 | — | — | EP | disclosed |
| EP-0431387-A1 | Basic polysaccharides | Wolff Walsrode Aktiengesellschaft (DE) | 1991-06-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210121499-A1 | THERAPEUTIC AGENT FOR HYPERPHOSPHATEMIA AND PARTICLES | PTH1R, SLC34A1, SLC20A1 | ALDH1A1 2035/4885CYP2C19 4704/4885CYP3A4 4755/4885 |
| US-11147833-B2 | Therapeutic agent for hyperphosphatemia | PHPT1, PPIP5K2, PTH1R | ALDH1A1 3982/4885CYP2C19 4156/4885CYP3A4 4835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.